Immunology and clinical manifestations of non-clonal mast cell activation syndrome

Diagnostic criteria and classification of mastocytosis: a consensus proposal

Valent, P., Horny, H., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Núñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,107 · see citing works

Integrated signalling pathways for mast-cell activation

Gilfillan, A. M., & Tkaczyk, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1782 · Cited by 955 · see citing works

Histamine and histamine intolerance

Maintz, L., & Novak, N. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1185 · Cited by 874 · see citing works

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Nagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S. H., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 871 · see citing works

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis

Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784 · see citing works

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750 · cited 3× · see citing works

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

Galli, S. J., Grimbaldeston, M. A., & Tsai, M. M. (2008) · Nature reviews. Immunology · doi:10.1038/nri2327 · Cited by 738 · see citing works

Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells

Re, F., & Strominger, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105927200 · Cited by 691 · see citing works

Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal

Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654 · see citing works

Mast cells and mastocytosis

Metcalfe, D. D. (2008) · Blood · doi:10.1182/blood-2007-11-078097 · Cited by 536 · see citing works

Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients

Brockow, K., Jofer, C., Behrendt, H., & Ring, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01569.x · Cited by 523 · see citing works

KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients

García‐Montero, A. C. (2006) · Blood · doi:10.1182/blood-2006-04-015545 · Cited by 502 · see citing works

Molecular regulation of mast cell activation

Rivera, J. Á., & Gilfillan, A. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.015 · Cited by 464 · see citing works

Differential release of mast cell mediators and the pathogenesis of inflammation

Theoharides, T. C., Kempuraj, D., Tagen, M., Conti, P., & Kalogeromitros, D. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00519.x · Cited by 425 · see citing works

Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations

Bodemer, C., Hermine, O., Palmérini, F., Yang, Y., Grandpeix-Guyodo, C., Leventhal, P. S., Hadj-Rabia, S., Nasca, L., Georgin-Lavialle, S., Cohen-Akenine, A., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.281 · Cited by 397 · see citing works

Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3

Kulka, M., Alexopoulou, L., Flavell, R. A., & Metcalfe, D. D. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.049 · Cited by 354 · see citing works

Mast cell activation syndrome: Proposed diagnostic criteria

Akin, C., Valent, P., & Metcalfe, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.035 · Cited by 327 · see citing works

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

Álvarez-Twose, I., González de Olano, D., Sánchez-Muñoz, L., Matito, A., Esteban-López, M. I., Vega, A., Mateo, M. B., Alonso Díaz de Durana, M. D., de la Hoz, B., del Pozo Gil, M. D., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.019 · Cited by 294 · see citing works

Toll‐like receptor 2 (TLR2) and TLR4 differentially activate human mast cells

Varadaradjalou, S., Féger, F., Thiéblemont, N., Benhamouda, N., Pléau, J., Dy, M., & Arock, M. (2003) · European Journal of Immunology · doi:10.1002/eji.200323830 · Cited by 293 · see citing works

The mast cell and allergic diseases: role in pathogenesis and implications for therapy

Brown, J. M., Wilson, T. M., & Metcalfe, D. D. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02886.x · Cited by 289 · see citing works

Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxis

Akin, C., Scott, L. M., Kocabas, C. N., Kushnir-Sukhov, N., Brittain, E., Noel, P., & Metcalfe, D. D. (2007) · Blood · doi:10.1182/blood-2006-06-028100 · Cited by 240 · see citing works

IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells

Kandere‐Grzybowska, K., Létourneau, R., Kempuraj, D., Donelan, J., Poplawski, S. E., Boucher, W. S., Athanassiou, A., & Theoharides, T. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4830 · Cited by 233 · see citing works

Hyperadrenergic Postural Tachycardia Syndrome in Mast Cell Activation Disorders

Shibao, C., Arzubiaga, C., Roberts, L. J., Raj, S., Black, B., Harris, P., & Biaggioni, I. (2005) · Hypertension · doi:10.1161/01.hyp.0000158259.68614.40 · Cited by 220 · see citing works

A Case of Intestinal Mastocytosis Misdiagnosed as Crohn's Disease

Reggiani, S., Cosso, L., Adriani, A., Pantaleoni, S., Risso, A., Vittone, F., Chiusa, L., Sapone, N., & Astegiano, M. (2015) · Case Reports in Gastroenterology · doi:10.1159/000430946 · Cited by 193 · see citing works

Diagnosis and Treatment of Cutaneous Mastocytosis in Children

Castells, M., Metcalfe, D. D., & Escribano, L. (2011) · American Journal of Clinical Dermatology · doi:10.2165/11588890-000000000-00000 · Cited by 193 · see citing works

Markers of Mast Cell Degranulation

Hogan, A. D., & Schwartz, L. B. (1997) · Methods · doi:10.1006/meth.1997.0494 · Cited by 178 · see citing works

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis

Carter, M. C., Robyn, J. A., Bressler, P. B., Walker, J. C., Shapiro, G. G., & Metcalfe, D. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.032 · Cited by 172 · see citing works

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Molderings, G. J., Brettner, S., Homann, J., & Afrin, L. B. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-10 · Cited by 149 · see citing works

Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)

Escribano, L., Dı́az-Agustı́n, B., López, A., Núñez, R., García‐Montero, A. C., Almeida, J., Prados, A., Angulo, M., Herrero, S., Órfão, A., et al. (2004) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.10072 · Cited by 148 · see citing works

Mastocytosis: Mediator-Related Signs and Symptoms

Castells, M., & Austen, K. F. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000048188 · Cited by 133 · see citing works

Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations

Hamilton, M. J., Hornick, J. L., Akin, C., Castells, M. C., & Greenberger, N. J. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.037 · Cited by 132 · see citing works

Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis

Escribano, L., Dı́az-Agustı́n, B., Bellas, C., Navalón, R., Núñez, R., Sperr, W. R., Schernthaner, G.-H., Valent, P., & Órfão, A. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00050-9 · Cited by 132 · see citing works

Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome

Sonneck, K., Florian, S., Müllauer, L., Wimazal, F., Födinger, M., Sperr, W. R., & Valent, P. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000096442 · Cited by 129 · see citing works

Exercise-induced anaphylaxis: A serious form of physical allergy associated with mast cell degranulation

Sheffer, A. L., Tong, A. K. F., Murphy, G. F., Lewis, R. A., McFadden, E. R., & Austen, K. F. (1985) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(85)80021-x · Cited by 129 · see citing works

Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a

Woolhiser, M. R. (2003) · Clinical Immunology · doi:10.1016/j.clim.2003.11.007 · Cited by 114 · see citing works

Mast cell mediators in allergic inflammation and mastocytosis

Castells, M. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.005 · Cited by 112 · see citing works

Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial

Frieri, M., Alling, D. W., & Metcalfe, D. D. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90454-1 · Cited by 110 · see citing works

Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders

Schwartz, L. B. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00020-0 · Cited by 110 · see citing works

Ultrastructural Evidence for Piecemeal and Anaphylactic Degranulation of Human Gut Mucosal Mast Cells in vivo

Dvořàk, A. M., McLeod, R. S., Onderdonk, A. B., Monahan-Earley, R. A., Cullen, J., Antonioli, D. A., Morgan, E. S., Blair, J. E., Estrella, P., Cisneros, R. L., et al. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236338 · Cited by 108 · see citing works

Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry

Dvořàk, A. M., Tepper, R., Weller, P. F., Morgan, E., Estrella, P., Monahan-Earley, R., & Galli, S. J. (1994) · Blood · doi:10.1182/blood.v83.12.3600.3600 · Cited by 95 · see citing works

Immunoreactivity for CD25 in Gastrointestinal Mucosal Mast Cells is Specific for Systemic Mastocytosis

Hahn, H. P., & Hornick, J. L. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318078ce7a · Cited by 93 · see citing works

gp49B1-αvβ3 interaction inhibits antigen-induced mast cell activation

Castells, M., Klickstein, L. B., Hassani, K., Cumplido, J., Lacouture, M. E., Austen, K. F., & Katz, H. R. (2001) · Nature Immunology · doi:10.1038/87749 · Cited by 91 · see citing works

Molecular Diagnosis of Mast Cell Disorders

Akin, C. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.060022 · Cited by 84 · see citing works

Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D<sub>2</sub> Production

Butterfield, J. H., & Weiler, C. R. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000144042 · Cited by 81 · see citing works

Inhibitory receptors and allergy

Katz, H. R. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00400-4 · Cited by 81 · see citing works

Biochemical Diagnosis of Systemic Mast Cell Disorders

Roberts, L. J., & Oates, J. A. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12468945 · Cited by 74 · see citing works

Multiple novel alterations in<i>Kit</i>tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder

Molderings, G. J., Kolck, U. W., Scheurlen, C., Brüss, M., Homann, J., & Von Kügelgen, I. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701245744 · Cited by 73 · see citing works

Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient

Douglass, J. A., Carroll, K., Voskamp, A. L., Bourke, P., Wei, A. H., & O’Hehir, R. E. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02259.x · Cited by 66 · see citing works

Detection of the major urinary metabolite of prostaglandin D2 in the circulation: Demonstration of elevated levels in patients with disorders of systemic mast cell activation

Awad, J. A., Morrow, J. D., & Roberts, L. J. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90371-9 · Cited by 66 · see citing works

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

Molderings, G. J., Raithel, M., Kratz, F., Azémar, M., Haenisch, B., Harzer, S., & Homann, J. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4640 · Cited by 63 · see citing works

Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects

Molderings, G. J., Meis, K., Kolck, U. W., Homann, J., & Frieling, T. (2010) · Immunogenetics · doi:10.1007/s00251-010-0474-8 · Cited by 58 · see citing works

Drug allergy in mast cell disease

Brockow, K., & Bonadonna, P. (2012) · Current Opinion in Allergy &amp; Clinical Immunology · doi:10.1097/aci.0b013e328355b7cb · Cited by 57 · see citing works

Mast Cell Activation Syndrome: A Review

Frieri, M., Patel, R., & Celestin, J. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0322-z · Cited by 56 · see citing works

Anaphylaxis and Mast Cell Disease: What Is the Risk?

Akin, C. (2010) · Current Allergy and Asthma Reports · doi:10.1007/s11882-009-0080-8 · Cited by 55 · see citing works

Cutting the cord: is birth already too late for primary prevention of allergy?

Brown, M. A., Halonen, M. J., & Martínez, F. D. (1997) · PubMed · Cited by 55 · see citing works

Cutting the cord: is birth already too late for primary prevention of allergy?

Brown, M. A., Halonen, M. J., & Martínez, F. D. (1997) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1997.tb00665.x · Cited by 55 · see citing works

A morphometric study of neovascularization in colorectal carcinoma

Pavlopoulos, P. M., Konstantinidou, A. E., Agapitos, E. B., Kavantzas, N., Nikolopoulou, P., & Davaris, P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 54 · see citing works

Differential Diagnosis of the Patient with Unexplained Flushing/Anaphylaxis

Metcalfe, D. D. (2000) · Allergy and Asthma Proceedings · doi:10.2500/108854100778249006 · Cited by 53 · see citing works

Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab

Bell, M. C., & Jackson, D. J. (2012) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2012.02.021 · Cited by 50 · see citing works

Piecemeal Degranulation of Basophils and Mast Cells Is Effected by Vesicular Transport of Stored Secretory Granule Contents

Dvořàk, A. M. (2005) · KARGER eBooks · doi:10.1159/000086516 · Cited by 49 · see citing works

Mast cell-related disorders presenting with Kounis syndrome

González‐de‐Olano, D., Matito, A., Sánchez-López, P., Sánchez‐Muñoz, L., Morgado, J. M., Teodósio, C., Jara‐Acevedo, M., García‐Montero, A. C., Orfao, A., Escribano, L., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.041 · Cited by 30 · see citing works

Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay

Sargur, R. B., Cowley, D., Murng, S. H. K., Wild, G., Green, K., Shrimpton, A., & Egner, W. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04287.x · Cited by 26 · see citing works

Determination of histamine in human plasma: the European external quality control study 1988

COSTING, E., Neugebauer, E. A. M., Keyzer, J. J., & Lorenz, W. (1990) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1990.tb02793.x · Cited by 26 · see citing works

Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase.

Weidner, N., Horan, R. F., & Austen, K. F. (1992) · PubMed · Cited by 22 · see citing works

Polycythemia From Mast Cell Activation Syndrome: Lessons Learned

Afrin, L. B., & Hamm, L. L. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31821d41dd · Cited by 21 · see citing works

Evaluation of mast cell activation syndromes: impact of pathology and immunohistology

Horny, H.-P., Sotlar, K., & Valent, P. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000336374 · Cited by 21 · see citing works

Burning mouth syndrome and mast cell activation disorder

Afrin, L. B. (2011) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2010.11.030 · Cited by 17 · see citing works

Acute nonlymphocytic leukemia in systemic mastocytosis with biclonal gammopathy

Lindner, P. S., Pardanani, B., Angadi, C., & Frieri, M. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80024-7 · Cited by 17 · see citing works

Lymphadenopathic mastocytosis with eosinophilia and biclonal gammopathy

Frieri, M., Linn, N., Schweitzer, M. E., Angadi, C., & Pardanani, B. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80132-0 · Cited by 17 · see citing works

Sclerosing mediastinitis and mast cell activation syndrome

Afrin, L. B. (2012) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.12.005 · Cited by 16 · see citing works

Manual of Critical Care

Cerra, F. B. (1987) · Cited by 16 · see citing works

Mast Cell Activation Syndrome Masquerading as Agranulocytosis

Afrin, L. B. (2012) · Military Medicine · doi:10.7205/milmed-d-11-00111 · Cited by 12 · see citing works

MAST CELL DISEASES AND THE SEVERITY AND COURSE OF INTRAOPERATIVE ANAPHYLAXIS

Bilò, M. B., Frontini, F., Massaccesi, C., Cinti, B., & Antonicelli, L. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60173-1 · Cited by 10 · see citing works

Elevated Baseline Tryptase Levels in Patients with Mast Cell Activation Syndromes without Evidence of Mastocytosis

Kassab, D., Koterba, A. P., Jiang, Y., & Akin, C. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.12.268 · Cited by 6 · see citing works

Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number

Lyons, J. J., Yu, X., Hughes, J. D., Le, Q. T., Jamil, A., Bai, Y., Ho, N., Zhao, M., Liu, Y., O'Connell, M. P., et al. (2016) · Nature Genetics · doi:10.1038/ng.3696 · Cited by 394 · see citing works

Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management

Castells, M., & Butterfield, J. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.02.002 · Cited by 135 · see citing works

AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management

Weiler, C. R., Austen, K. F., Akin, C., Barkoff, M. S., Bernstein, J. A., Bonadonna, P., Butterfield, J. H., Carter, M., Fox, C. C., Maitland, A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.023 · Cited by 123 · see citing works

The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS)

Kucharik, A. H., & Chang, C. (2020) · Clinical Reviews in Allergy &amp; Immunology · doi:10.1007/s12016-019-08755-8 · Cited by 122 · see citing works

Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?

Theoharides, T. C., Tsilioni, I., & Ren, H. L. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1596800 · Cited by 124 · see citing works

Mast cell disorders in Ehlers-Danlos syndrome

Seneviratne, S. L., Maitland, A., & Afrin, L. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31555 · Cited by 107 · see citing works

Clinical characteristics and risk profile of patients with elevated baseline serum tryptase

Fellinger, C., Hemmer, W., Wöhrl, S., Sesztak‐Greinecker, G., Jarisch, R., & Wantke, F. (2014) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2014.05.002 · Cited by 89 · see citing works

Expanding Spectrum of Mast Cell Activation Disorders: Monoclonal and Idiopathic Mast Cell Activation Syndromes

Picard, M., Junior, P. F. G.-B., Mezzano, V., & Castells, M. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.001 · Cited by 77 · see citing works

Often seen, rarely recognized: mast cell activation disease – a guide to diagnosis and therapeutic options

Afrin, L. B., Butterfield, J. H., Raithel, M., & Molderings, G. J. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1161231 · Cited by 74 · see citing works

Presentation and Diagnosis of Hypersensitivity to Platinum Drugs

Caiado, J., & Castells, M. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0515-3 · Cited by 72 · see citing works

Are Mast Cells Still Good Biomarkers for Bladder Pain Syndrome/Interstitial Cystitis?

Gamper, M., Regauer, S., Welter, J., Eberhard, J., & Viereck, V. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.01.036 · Cited by 69 · see citing works

Mast Cell Activation Syndrome

Frieri, M. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8487-6 · Cited by 65 · see citing works

Spectrum of mast cell activation disorders

Petra, A. I., Panagiotidou, S., Stewart, J. M., Conti, P., & Theoharides, T. C. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.906302 · Cited by 54 · see citing works

Patient perceptions in mast cell disorders

Jennings, S. V., Slee, V. M., Zack, R. M., Verstovsek, S., George, T. I., Shi, H., Lee, P., & Castells, M. C. (2018) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2018.04.006 · Cited by 53 · see citing works

Mastocytosis: update on pharmacotherapy and future directions

Cardet, J. C., Akin, C., & Lee, M. J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.824424 · Cited by 49 · see citing works

The genetic basis of mast cell activation disease - looking through a glass darkly

Molderings, G. J. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.09.001 · Cited by 50 · see citing works

Mast cell activation syndrome: Current understanding and research needs

Castells, M., Giannetti, M. P., Hamilton, M. J., Novak, P., Pozdnyakova, O., Nicoloro-SantaBarbara, J., Jennings, S. V., Francomano, C., Kim, B., Glover, S. C., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.05.025 · Cited by 45 · see citing works

Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers‐Danlos syndrome/hypermobility spectrum disorder

Brock, I., Prendergast, W., & Maitland, A. L. (2021) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31940 · Cited by 39 · see citing works

H1‐antihistamines for primary mast cell activation syndromes: a systematic review

Nurmatov, U. B., Rhatigan, E., Simons, F. E. R., & Sheikh, A. (2015) · Allergy · doi:10.1111/all.12672 · Cited by 39 · see citing works

Diagnostic Tools for Hypersensitivity to Platinum Drugs and Taxanes: Skin Testing, Specific IgE, and Mast Cell/Basophil Mediators

Caiado, J., & Picard, M. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0451-7 · Cited by 36 · see citing works

The Role of Mast Cells in the Induction and Maintenance of Inflammation in Selected Skin Diseases

Woźniak, E., Owczarczyk-Saczonek, A. B., Lange, M., Czarny, J. H., Wygonowska, E., Placek, W. J., & Nedoszytko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087021 · Cited by 35 · see citing works

Genetic characteristics of Jiaji Duck by whole genome re-sequencing

Gu, L., Wang, F., Lin, Z., Xu, T., Lin, D., Xing, M., Yang, S., Chao, Z., Ye, B., Lin, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228964 · Cited by 31 · see citing works

Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis

Caiado, J., & Castells, M. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01014-x · Cited by 29 · see citing works

Impact of Probiotic Bacteria on Respiratory Allergy Disorders

Jakubczyk, D., & Górska, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.688137 · Cited by 28 · see citing works

Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence

Szukiewicz, D., Wojdasiewicz, P., Wątroba, M., & Szewczyk, G. (2022) · Journal of Immunology Research · doi:10.1155/2022/9534163 · Cited by 22 · see citing works

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes

González‐de‐Olano, D., Matito, A., Órfão, A., & Escribano, L. (2016) · F1000Research · doi:10.12688/f1000research.9565.1 · Cited by 21 · see citing works

Hereditary alpha-tryptasemia

Bonadonna, P., Nalin, F., & Olivieri, F. (2022) · Current Opinion in Allergy &amp; Clinical Immunology · doi:10.1097/aci.0000000000000849 · Cited by 18 · see citing works

Depression, psychosocial correlates, and psychosocial resources in individuals with mast cell activation syndrome

Nicoloro SantaBarbara, J., & Lobel, M. (2022) · Journal of Health Psychology · doi:10.1177/13591053211014583 · Cited by 17 · see citing works

Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation

Butterfield, J. H. (2019) · International Archives of Allergy and Immunology · doi:10.1159/000503964 · Cited by 16 · see citing works

Successful treatment of idiopathic mast cell activation syndrome with low-dose omalizumab

Berry, R., Hollingsworth, P., & Lucas, M. (2019) · Clinical &amp; Translational Immunology · doi:10.1002/cti2.1075 · Cited by 15 · see citing works

Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond

Jennings, S. V., Finnerty, C. C., Hobart, J. S., Martín‐Martinez, M., Sinclair, K. A., Slee, V. M., Agopian, J., Akin, C., Álvarez‐Twöse, I., Bonadonna, P., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.06.018 · Cited by 12 · see citing works

Mast Cell Activation

Khokhar, D. S., & Akin, C. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.09.002 · Cited by 10 · see citing works

Mast Cell Biology and Linkages for Non-clonal Mast Cell Activation and Autoimmune/Inflammatory Syndrome Induced by Adjuvants

Cimolai, N. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00494-8 · Cited by 9 · see citing works

Comparing histamine intolerance and non-clonal mast cell activation syndrome

Cimolai, N. (2020) · Intestinal Research · doi:10.5217/ir.2019.00087 · Cited by 8 · see citing works

Prostaglandin D2-supplemented “functional eicosanoid testing and typing” assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study

Schäfer, D., Dreßen, P., Brettner, S., Rath, N.-F., Molderings, G. J., Jensen, K., & Ziemann, C. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0213-2 · Cited by 7 · see citing works

Mast Cell Activation Syndromes

Bonamichi-Santos, R., & Castells, M. (2016) · Current Treatment Options in Allergy · doi:10.1007/s40521-016-0100-6 · Cited by 9 · see citing works

Management of indolent mastocytosis and mast cell activation syndrome

Akin, C., Butterfield, J. H., Castells, M., & Lyons, J. J. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.06.032 · Cited by 4 · see citing works

Estudo da conjugação da IL-2 com o peptídeo apoptótico pep5, no contexto das doenças autoimunes e inflamatórias

Valencia, A. O. (2021) · doi:10.11606/t.9.2021.tde-14122021-133005

Parasympathetic and Sympathetic Nervous System Dysfunction and Monitoring

DePace, N. L., Soloway, S., Yayac, M. F., & Colombo, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-88769-7_13

[NON-CLONAL MAST CELL ACTIVATION SYNDROME: DESCRIPTION OF SERIES OF PATIENTS, DIAGNOSTIC CRITERIA AND TREATMENT].

Confino‐Cohen, R., & Mekori, Y. A. (2015) · PubMed

Nonclonal Mast Cell Activation Syndrome

Hamilton, M. J. (2018) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2018.04.002 · Cited by 34 · see citing works

Mast cell activation syndromes in clinical practice: diagnostic challenges, phenotypes, and real-life management

Katran, Z. Y., Argın, Ö., Erdem, S., & Bulut, İ. (2026) · Advances in Dermatology and Allergology · doi:10.5114/ada.2026.162040

Mast cell activation syndrome — clinical presentation and diagnostic criteria

Boldeanu, E.-S., Avram, M., & Rezmeriţă, L. (2021) · Alergologia · doi:10.26416/aler.5.1.2021.4445 · Cited by 1 · see citing works

Mast Cell Activation

Khokhar, D. S., & Akin, C. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.09.002 · Cited by 10 · see citing works